US pharmaceutical firm Lilly is re-entering the infectious diseases market in a big way with the acquisition of three ...
The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr ...
Eli Lilly and Co (NYSE:LLY) has announced agreements to acquire three vaccine developers, Curevo, LimmaTech Biologics AG, and ...
Shares of Eli Lilly rose 0.9% shortly after the market opened. "These acquisitions reflect a deliberate strategy to prevent ...
Eli Lilly said on Tuesday it will buy three vaccine developers in deals worth up to nearly $4 billion in combined ...
Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...
The vaccine development news offers fresh hope as the deadly outbreak in the Democratic Republic of Congo and Uganda ...
With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.
India can boost Ebola vaccine, antibody development through WHO lab network, ICMR: Ex-WHO Chief Scientist ...
WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today that its drug substance facility (MFG23) ...
A decade after Ebola vaccines changed outbreak response, a new epidemic in central Africa is caused by a strain the world ...
The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results